Trials / Terminated
TerminatedNCT06535009
Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
A Phase I, Open-label, Uncontrolled, Dose Escalation Study to Evaluate the Tolerability and Safety of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Advanced or Metastatic Solid Tumors
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is dose escalation study to evaluate the tolerability and safety of ONO-7914 alone and in combination with ONO-4538 in patients with advanced or metastatic solid tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-7914 | Specified dose on specified days |
| DRUG | ONO-4538 | Specified dose on specified days |
Timeline
- Start date
- 2022-02-08
- Primary completion
- 2025-02-26
- Completion
- 2025-02-26
- First posted
- 2024-08-02
- Last updated
- 2025-06-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06535009. Inclusion in this directory is not an endorsement.